| 8 |
8
제7항에 있어서,상기 n-형 분자는 3,9-비스(2-메틸렌-(3-(1,1-다이시아노메틸렌)-인다논))-5,5,11,11-테트라키스(4-헥실페닐)-다이티아노[2,3-d:2',3'-d']-s-인다세노[1,2-b:5,6-b']다이티오펜(ITIC), 3,9-bis(2-methylene-(5,6-difluoro-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile)-5,5,11,11-tetrakis(4-hexylphenyl)-dithieno[2,3-d:2′,3′-d′]-s-indaceno[1,2-b:5,6-b′]dithiophene (IT-4F) (5Z,5'Z)-5,5'-(((4,4,9,9-tetraoctyl-4,9-dihydro-s-indaceno[1,2-b:5,6-b']dithiophene-2,7-diyl)bis(benzo[c][1,2,5]thiadiazole-7,4-diyl))bis(methanylylidene))bis(3-ethyl-2-thioxothiazolidin-4-one) (O-IDTBR), 2,2'-((2Z,2'Z)-(((4,4,9,9-tetrakis(4-hexylphenyl)-4,9-dihydro-sindaceno[1,2-b:5,6-b']dithiophene-2,7-diyl)bis(4-((2-ethylhexyl)oxy)thiophene-5,2- diyl))bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile (IEICO-4F) 5,5'-(9,9'-spirobi[fluorene]-2,7-diyl)bis(2,9-dimethylanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetraone) (SF-PDI2), (2,20-((2Z,20Z)-((12,13-bis(2-ethylhexyl)-3,9-diundecyl-12,13-dihydro-[1,2,5]thiadiazolo[3,4-e]thieno[2,"3':4',5']thieno[2',3':4,5]pyrrolo[3,2-g]thieno[2',3':4,5]thieno[3,2-b]indole-2,10-diyl)bis(methanylylidene))bis(5,6-difluoro-3-oxo-2,3-dihydro-1H-indene-2,1-diylidene))dimalononitrile) (Y6), (6,6)-페닐-C61-부티릭에시드 메틸에스테르(C60-PCBM), (6,6)-페닐-C71-부티릭에시드 메틸에스테르(C70-PCBM), 비스(1-[3-(메톡시카르보닐)프로필]-1-페닐)(Bis-C60-PCBM), 3'-페닐-3'H-시클로프로파(8,25)(5,6)플러렌-C70-비스-D5h(6)-3'-부티르산 메틸 에스테르(Bis-C70-PCBM), 인덴-C60-비스어덕트(ICBA), 모노인덴닐C60(ICMA) 및 이들의 조합으로 이루어진 군으로부터 선택되는 어느 하나인 것을 특징으로 하는 자가치유 광활성층 형성용 조성물
|
